PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Brain Diseases, Center for Biomedical Sciences, Korea National Institute of Health, 187 Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, 28159, South Korea.\', \'Division of Brain Diseases, Center for Biomedical Sciences, Korea National Institute of Health, 187 Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, 28159, South Korea. Electronic address: kohyh122@korea.kr.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0006-291X(20)31150-510.1016/j.bbrc.2020.05.203
?:doi
?:hasPublicationType
?:journal
  • Biochemical and biophysical research communications
is ?:pmid of
?:pmid
?:pmid
  • 32513532
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.087
?:rankingScore_hIndex
  • 237
is ?:relation_isRelatedTo_publication of
?:title
  • Altered COVID-19 receptor ACE2 expression in a higher risk group for cerebrovascular disease and ischemic stroke.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all